Israel Offers COVID-19 Booster Shots to Anyone Over 60
Announcement comes amid increasing infections and indications that the vaccine's efficacy fades over time
McCormick Recalls Seasonings Over Salmonella Risk
No illnesses associated with the recalled products have been reported
Racial/Ethnic Disparities Persist in Adult Vaccination Coverage
Socioeconomic differences in flu vaccine uptake narrowed for those aged 18 to 64 years, but racial/ethnic, SES differences persisted for ≥65s
Most With Reaction to mRNA COVID-19 Vaccine Tolerate Second Dose
Most patients with immediate, potentially allergic reaction to Pfizer-BioNTech or Moderna mRNA COVID-19 vaccine tolerate second dose
Sickle Cell Disease May Up Risk for Poor COVID-19 Outcomes
Sickle cell trait also associated with increased risk for COVID-19-related hospitalization and death, but to a lesser extent
Cognitive Impairment Reported After COVID-19 Infection
Cognitive impairment identified in cohort of older Amerindians and in 32 patients after mild-to-moderate COVID-19
CDC Now Says Vaccinated Should Be Tested After COVID-19 Exposure, Even Without Symptoms
Even though fully vaccinated people may still get infected, infections tend to have mild or no symptoms
Mississippi Health System Buckles Under ‘Astounding’ Rise in COVID-19 Cases
Compared with the first half of July, the number of infections more than doubled in the past two weeks and deaths rose by 51 percent
Third COVID-19 Vaccine Dose May Prompt Response in Transplant Recipients
Third dose of mRNA-1273 vaccine induces serologic response in 49 percent of kidney recipients who did not respond after two doses
Shorter Course of Antibiotics Noninferior for UTI in Afebrile Men
Seven days of antibiotics noninferior to 14-day course for resolution of symptoms among afebrile men with urinary tract infection
